CHELSEA ROBERTS: Open Payments
NPI 1417478454 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,248 in 46 payments from 16 companies in 2025. Trend: 2023 $2,608 · 2024 $2,661 · 2025 $1,248
Food & beverage: $1,248
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $231 |
| PFIZER INC. | 10 | $214 |
| Janssen Biotech, Inc. | 8 | $170 |
| Procept Biorobotics Corporation | 1 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| CIVCO Medical Instruments | 1 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Endo USA, Inc. | 3 | $53 |
| Medtronic, Inc. | 1 | $51 |
Products named: XTANDI, GEMTESA, ERLEADA, AQUABEAM ROBOTIC SYSTEM, LYNPARZA, PLUVICTO, KEYTRUDA, XIAFLEX.
Industry payments across PA — which companies pay providers there.
